|
1.
|
Wiley NJ, Madhankumar AB, Michell RM, Neely EB, Rizk E, Douds GL, Simmons Z, Connor JR
. Advances in Nanoparticles. Lipopolysaccharide Modified Liposomes for Amyotropic Lateral Sclerosis Therapy: Efficacy in SOD1 Mouse Model. 2012; 1(3):44-53.
|
|
|
|
|
2.
|
Liu X, Madhankumar AB, Slagle-Webb B, Sheehan JM, Surguladze N, Connor JR. Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents. Cancer Res. 2011 Mar 15; 71(6):2240-9.
|
|
|
|
|
3.
|
Madhankumar AB, Slagle-Webb B, Wang X, Yang QX, Antonetti DA, Miller PA, Sheehan JM, Connor JR. Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model. Mol Cancer Ther. 2009 Mar; 8(3):648-54.
|
|
|
|
|
4.
|
Mintz A, Gibo DM, Madhankumar AB, Cladel NM, Christensen ND, Debinski W. Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2. Cancer Biother Radiopharm. 2008 Oct; 23(5):581-9.
|
|
|
|
|
5.
|
Fisher J, Devraj K, Ingram J, Slagle-Webb B, Madhankumar AB, Liu X, Klinger M, Simpson IA, Connor JR. Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am J Physiol Cell Physiol. 2007 Aug; 293(2):C641-9.
|
|
|
|
|
6.
|
Madhankumar AB, Slagle-Webb B, Mintz A, Sheehan JM, Connor JR. Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme. Mol Cancer Ther. 2006 Dec; 5(12):3162-9.
|
|
|
|
|
7.
|
Madhankumar AB, Mintz A, Debinski W. Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2. Neoplasia. 2004 Jan-Feb; 6(1):15-22.
|
|
|
|
|
8.
|
Mintz A, Gibo DM, Madhankumar AB, Debinski W. Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma. J Neurooncol. 2003 Aug-Sep; 64(1-2):117-23.
|
|
|
|
|
9.
|
Madhankumar AB, Mintz A, Debinski W. Alanine-scanning mutagenesis of alpha-helix D segment of interleukin-13 reveals new functionally important residues of the cytokine. J Biol Chem. 2002 Nov 8; 277(45):43194-205.
|
|
|
|
|
10.
|
Madhan Kumar AB, Panduranga Rao K. Preparation and characterization of pH-sensitive proteinoid microspheres for the oral delivery of methotrexate. Biomaterials. 1998 Apr-May; 19(7-9):725-32.
|
|
|
|
|
11.
|
A.B. Madhan Kumar, K. Panduranga Rao. Poly(palmitoyl-l-hydroxyproline ester) microspheres as potential oral controlled drug delivery system. International Journal of Pharmaceutics. 1997; 149(1):107-114.
|
|
|
|
|
12.
|
A. B. Madhan Kumar, R. Jayakumar, K. Panduranga Rao. Synthesis and aggregational behavior of acidic proteinoid. Journal of Polymer Science A-Polymer Chemistry. 1996; 34(14):2915-2924.
|
|
|
|